Latest News

COVID vaccination rates among pregnant people remain low


 

COVID vaccination rates among pregnant people remain low, despite data that shows the vaccines can prevent the high risk of severe disease during pregnancy.

About 30% of pregnant people are vaccinated, according to the latest CDC data, with only 18% obtaining a dose during pregnancy. Health officials have been tracking the timing of vaccination before and during pregnancy.

The vaccination rates are even lower among pregnant Black people, CDC data shows. About 15% are fully vaccinated, compared with 25% of pregnant Hispanic and Latino people, 34% of pregnant White people, and 46% of pregnant Asian people.

“This puts them at severe risk of severe disease from COVID-19,” Rochelle Walensky, MD, the CDC director, said during a news briefing with the White House COVID-19 Response Team.

“We know that pregnant women are at increased risk of severe disease, of hospitalization and ventilation,” she said. “They’re also at increased risk for adverse events to their baby.”

Those who give birth while infected with COVID-19 had “significantly higher rates” of intensive care unit admission, intubation, ventilation, and death, according to a recent study published in JAMA Network Open.

Dr. Walensky said on Sept. 28 that studies show COVID-19 vaccines can be taken at any time while pregnant or breastfeeding. She noted that the vaccines are safe for both mothers and their babies.

“We’ve actually seen that some antibody from the vaccine traverses [the placenta] to the baby and, in fact, could potentially protect the baby,” she said.

Public health officials say the low vaccination rates can be attributed to caution around the time of pregnancy, concern for the baby, barriers to health care, and misinformation promoted online.

“Pregnancy is a precious time. It’s also a time that a lot of women have fear,” Pam Oliver, MD, an obstetrics and gynecology doctor and executive vice president of North Carolina’s Novant Health, told USA Today.

“It is natural to have questions,” she said. “So, let’s talk about what we know, let’s put it in perspective.”

A version of this article first appeared on Medscape.com.

Recommended Reading

COVID-19 a rare trigger for Guillain-Barré syndrome
Journal of Clinical Outcomes Management
What I Learned About Change From Practicing During the COVID-19 Surge
Journal of Clinical Outcomes Management
Feasibility of a Saliva-Based COVID-19 Screening Program in Abu Dhabi Primary Schools
Journal of Clinical Outcomes Management
Virtual Visitation: Exploring the Impact on Patients and Families During COVID-19 and Beyond
Journal of Clinical Outcomes Management
Top questions answered about COVID-19 boosters for your patients
Journal of Clinical Outcomes Management
These schools use weekly testing to keep kids in class – and COVID out
Journal of Clinical Outcomes Management
Polyethylene glycol linked to rare allergic reactions seen with mRNA COVID-19 vaccines
Journal of Clinical Outcomes Management
Children and COVID: New cases topped 200,000 after 3 weeks of declines
Journal of Clinical Outcomes Management
COVID-19 hospitalization 80% more likely for smokers
Journal of Clinical Outcomes Management
Age, C-reactive protein predict COVID-19 death in diabetes
Journal of Clinical Outcomes Management